Health1 hour ago
FDA Extends Review of Vanda Pharmaceuticals’ Tradipitant Hold
The United States Food and Drug Administration (FDA) has announced a brief extension to its re-review of the partial clinical hold on Vanda Pharmaceuticals’ investigational drug,...
